SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-012926
Filing Date
2022-05-12
Accepted
2022-05-12 08:16:40
Documents
14
Period of Report
2022-05-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40488
2 ex99-1.htm EX-99.1 152683
3 ex99-1_001.jpg GRAPHIC 3224
  Complete submission text file 0001493152-22-012926.txt   382759

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT indp-20220512.xsd EX-101.SCH 3039
5 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT indp-20220512_lab.xml EX-101.LAB 34476
6 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT indp-20220512_pre.xml EX-101.PRE 22599
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3538
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 347-480-9760
Indaptus Therapeutics, Inc. (Filer) CIK: 0001857044 (see all company filings)

IRS No.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40652 | Film No.: 22915810
SIC: 2834 Pharmaceutical Preparations